-
Actice Absorption
Movement of drug particles from the gastrointestinal tract to body fluids; requires a carrier, such as an enzyme or protein, to move the drug against a concentration gradient.
-
Adverse Reactions
Reactions to drugs that are more severe than side effects
-
Agonists
Drugs that produce a response
-
Antagonists
Drugs that block a response
-
Bioavailability
The percentage of an administered drug dose that reaches the systemic circulation
-
Creatinine Clearance (CLcr)
A diagnostic test that determines renal function
-
Disintegration
The breakdown of a tablet into smaller particles
-
Dissolution
The dissolving of the smaller particles of a tablet in the gastrointestinal fluid before absorption
-
Distribution
The process by which the drug becomes available to body fluids and body tissues
-
Duration of action
The length of time the drug has a pharmacologic effect
-
Elimination
Exretion of a drug, mainly through the kidneys (urine). Other routes of elimination include hepatic metabolism, bile, feces, lungs, saliva, sweat, and breast milk.
-
Excipients
Fillers and inert substances found in tablets
-
First-pass effect
The process in which a drug passes to the liver first
-
Free drugs
Drugs not bound by protein
-
Half-life
The time it takes for one half of a drug concentration to be eliminated
-
High therapeutic index
Drugs with a wide margin of safety and less danger of producing toxic effects
-
Ligan-binding domain
The site on the receptor in which drugs bind
-
Loading dose
A large intentional dose of drug given when an immediate drug response is desired to achieve a rapid minimum effective concentration on plasma
-
Low therapeutic index
Drugs with narrow margin of safety for which the drug effect should be closely monitored
-
Metabolism
Occurs in the gastrointestinal tract and liver; however, the liver is the primary site
-
Nonselective drugs
Drugs that affect various receptors
-
Nonspecific drugs
Drugs that affect various sites
-
Onset
The time it takes to reach the minimum effective concentration (MEC) after a drug is administered.
-
Passive absorption
Movement of drug particles from the gastrointestinal tract to body fluids that occurs mostly by diffusion (movement from higher concentration to lower concentration)
-
Peak
When drug reaches its highest blood plasma concentration
-
Peak drug level
The highest concentration of a drug at a specific time
-
Pharmaceutic phase
The first phase of drug action
-
Pharmacodynamics
The study of drug concentration and its effects on the body
-
Pharmacogenetics
The effect of a drug action that varies from a predicted drug response because of genetic factors or hereditary influence
-
Pharmacokinetics
The process of drug movement to achieve drug action
-
Pinocytosis
The process by which cells carry drugs across their membrane by engulfing the drug particles
-
Placebo effect
A psychological benefit from a compound that may not have the chemical structure of a drug effect
-
Rate limiting
The time it takes a drug to disintegrate and dissolve, becoming available for the body to absorb it
-
Receptor families
Four families, including (1) kinase-linked receptors, (2) ligand-gated ion channels, (3) G protein-coupled receptor systems, (4) nuclear receptors
-
Side effects
Physiologic effects of drugs not related to desired effects of drugs
-
Tachyphylaxis
A rapid decrease in a response to a drug
-
Therapeutic index (TI)
Estimates the margin of safety of a drug through the use of a ratio that measures the effective (therapeutic or concentration) dose (ED) in 50% of persons or animals (ED50) and the lethal dose (LD) in 50% of animals (LD50)
-
Therapeutic range (therapeutic window)
The range of drug concentration in plasma, which should be between the minimum effective concentration in the plasma for obtaining a desired drug action and the minimum toxic concentration, or the toxic effect.
-
Time-response curve
Evaluates three parameters of drug action; (1) the onset of drug action, (2) peak aciton and (3) duration of action
-
Tolerance
A decreased responsiveness over the course of drug therapy
-
Toxic effects
The first adverse symptoms that occur at a particular dose. Toxic effects can be identified by monitoring the plasma (serum) therapeutic range of the drug
-
Toxicity
The first adverse symptoms that occur at a particular dose. Toxicity can be identified by monitoring the plasma therapeutic range of the drug
-
Trough
The lowest plasma concentration of a drug, which measures the rate at which the drug is eliminated
-
Assessment
The first phase of the nursing process
-
Culturally sensitive
An awareness of culture implications for a client and/or the client's family
-
Evaluation
The phase of the nursing process that addresses the effectiveness of health teaching about drug therapy and the attainment of goals
-
Goal setting
Expected outcomes for a client, determined during the planning phase of the nursing process
-
Implementation
The phase of the nursing process that includes the nursing actions and interventions necessary to accomplish the established goals or expected outcomes
-
Nursing diagnosis
A diagnosis made by a registered nurse based on analysis of the assessment data
-
Planning
The phase of the nursing process characterized by goal setting or expected outcomes; it also includes development of nursing interventions that will be used to assist the client in meeting outcomes
-
Buccal
Medication placed between the gum and the cheek
-
Cumulative effect
When a drug is metabolized or excreted more slowly than the rate at which its being administered
-
Informed consent
Ensuring an individual has the knowledge necessary to make a medical decision, which is critical to preventing medication errors
-
Inhalation
Medication given via aerosol sprays
-
Instillations
Medication given in the nose, eyes or ears
-
Intradermal
A type of injection used for observation of an inflammatory (allergic) reaction to foreign particles
-
Intramuscular (IM)
A type of injection used for irritating drugs, aqueous suspensions, and solutions in oils
-
Intravenouse (IV)
An injection in an accessible peripheral vein
-
Meniscus
The line for determining the desired dose of a liquid drug
-
metered-dose inhaler (MDI)
Hand-held devices that deliver medications to oropharyngeal and lower respiratory tracts
-
Parenteral
Medication administered ID, SQ, IM, IV
-
Right assessment
Collecting appropriate data before administration of a drug
-
Right client
Using two forms of identificatin prior to the administration of medication
-
Right documentation
Immediately record appropriate information regarding drug. (1) name of drug, (2) dose, (3) route or injection site, (4) time and date, (5) nurse's signature or intitials
-
Right dose
The dose prescribed for that particular client
-
Right drug
Determining the client receives the correct drug that was prescribed
-
Right evaluation
Requires the effectiveness of a medication be determined by the client's response to the medication
-
Right route
Administering the correct form of drug to ensure appropriate absorption
-
Right time
The time at which a prescribed dose should be administered
-
Right to education
Requires that a client receive accurate and thorough information about a medication and how it relates to his or her particular situation
-
Right to refuse
A client's choice to decide against taking a medication
-
Spacers
Devices used to enhance the delivery of meds for MDIs
-
Stock drug method
Process by which drugs are dispensed to all clients from the same containers
-
Subcutaneouse (SQ)
An injection used for small drugs of non irritating, water-soluble drugs
-
Sublingual
Med placed under the tongue for venous absorption
-
Suppository
Med admin rectally or vaginally
-
Tolerance
A decreased responsiveness over the course of drug therapy
-
Topical
Med applied to the skin
-
Transdermal
Med stored in a patch placed on the skin and absorbed through the skin, thereby having a systemic effect
-
Unit dose method
Process by which drugs are individually wrapped and labeled for single doses
-
Z-track technique
An injection that prevents medication from leaking back into the SQ tissue. It is frequently advised for meds that cause visible permanent skin discolorations
-
Biocultural ecology
Includes concepts r/t biologic variations, heredity, genetics, endemics, and drug metabolism
-
Ethnocultural
A combo of ethnic and cultural variables
-
Ethnopharmacology
A new domain that integrates pharmacodynamics and pharmacokinetics with genetic and ethnic variations
-
Spatial distancing
The physical proximity between people conversing varies between and among cultural groups
-
Temporality
The perspective of time that determines whether a client stresses a past, present or future orientation
-
Chronological age
The actual age
-
Developmental age
The develomental and cognitive differences from a child's chronological age, to be considered when administering meds
-
Nonadherance
A client's failure to follow a drug regimen. Esp problematic with older adults
-
Noncompliance
A client's failure to follow a drug regimen
-
Polypharmacy
Administration of many drugs together
-
Fat-soluble vitamins
Vitamins that are metabolized slowly and can be stored in the fatty tissue, liver, and muscle in large amounts. They are excreted in the urine at a slow rate.
A,D,E,K
-
Iron
A mineral vital for hemoglobin regeneration
-
Megavitamin therapy
Admin massive doses of vitamins.
-
Mineral
A compound needed for the body to function, such as iron, copper, zinc, chromium and selenium
-
Recommended dietary allowance (RDA)
Daily dose requirements of each vitamin published by the National Academy of Sciences Food and Nutrition Board
-
Water-soluble vitamins
The B-complex vitamins and vitamin C
-
Anion
The negative charge of electrolytes
-
Cation
The positive charge of electrolytes
-
Electrolytes
Substances in the body that carry either a positive or negative charge
-
Hypercalcemia
A calcium level greater than 5.5 mEq/L
-
Hyperchloremia
An elevated chloride serum level
-
Hyperkalemia
A serum potassium level greater than 5.3 mEq/L
-
Hypermagnesemia
A magnesium excess
-
Hypernatremia
A serum sodium level greater than 145mEq/L
-
Hyperosmolar
Body fluid that has more particles than water
-
Hyperphosphotatemia
A decreased level of phosphorous.
-
Hypocalcemia
A calcium deficit of of less than 4.5 mEq/L
-
Hypochloremia
A decreased chloride level
-
Hypokalemia
A serum potassium level less than 3.5 mEq/L
-
Hypomagnesemia
A magesium deficit
-
Hypoosmolar
Body fluid that has fewer particles than water
-
Isoosmolar
Body fluid that has the same proportion of weight of particles and water
-
Osmolality
The concentration of body fluids
-
Tonicity
The effect of fluid on cellular volume
-
Bolus
Method used to deliver enteral feedings whereby 250 to 400 ml of solution is rapidly administered through a syringe or funnel into a tube four to six times daily
-
Continuous feedings
Enteral feedings rx for the critically ill or those who receive feedings into the small intestine given by an infusion pump at a slow rate over 24 hours
-
Cyclic method
A type of continuous feeding that is infused over 8 to 16 hours daily
-
Enteral nutrition
Feedings involving the gastrointestinal tract that can be given orally or by feeding tubes.
-
Hyperalimentation (HA)
Adminsitering high-caloric nutrients through the subclavian vein
-
Intermittent enteral feedings
Feedings admin Q 3-6h over 30-60 min by gravity drip or pump infusion
-
Intermittent infusion
An inexpensive method for admin enteral nutrition
-
NG tube
The most common route for short-term enteral feedings; given through oral or nasal cavities
-
Parenteral nutrition
Admin high-caloric nutrients through large veins
-
TPN
Admin high-caloric nutrition through subclavian vein
-
Valsalva maneuver
A technique to prevent air embolism in which a client must take a breath, hold it, bear down while the nurse is chaning infusion bags or bottles and tubing for TPN
-
Acute pharyngitis
Inflammatin of the throat "sore throat"
-
Acute rhynitis
Acute inflammation of the mucous membranse of the nose
-
Allergic rhinitis
Often called hay fever; this is caused by pollen or a foreing substance
-
Antihistamines
H1 blockers or H1 antagonists that compete with histamine receptor sites, thus preventing a histamine response
-
Antitussives
Drugs that can act on the cough-control center in the medulla to suppress the cough reflex
-
Common cold
The most prevalent type of URI
-
Decongestants
Sympathomimetic amines
-
Expectorants
Drugs that loosen bronchial secretions so that they can be eliminated by coughing
-
Rebound nasal congestion
Rebound vasal dilation instead of vasoconstriction
-
Rhinorrhea
Watery nasal d/c
-
Sinusitis
An inflammation of the mucous membranes of one or more of the maxillary, frontal, ethmoid, or sphenoid sinuses
-
Asthma
An inflammatory disorder of the airway walls with varying amounts of the airway obstruction
-
Bronchial asthma
A COPD disease charac by periods of bronchospasm resulting in wheezing and difficulty breathing
-
Bronchiectasis
Abnormal dilation of the bronchi and bronchioles secondary to frequent infections and inflammation
-
Bronchodilators
Drugs that include sympathomimetics (primarily beta2-adrenergic agonists), methylxanthines, leukotriene agonists, glucocorticoids, cromlyn, anticholinergics, and mucolytics
-
Bronchospasm
Also bronchoconstriction; results when the lung tissue is exposed to extrinsic or intrinsic factors that stimulate a bronchoconstrictive response
-
Chronic bronchitis
A progessive lung disease caused by smoking or chronic lung infections
-
COPD
Disease caused by airway obstruction, with increased airway resistance of airflow to lung tissues
-
Emphysema
A progressive lung disease caused by cigarette smoking, atmospheric contaminants, or lack of alpha1-antitrypsin protein that inhabits proteolytic enzymes that destroy alveoli (air sacs)
-
Glucocorticoids
Members of the corticosteroid family that are used to treat resp disorders, particularly asthma
-
Mucolytics
Drugs that act like detergents by liquefying and loosening thich mucous secretions so that they can be expectorated
-
Restrictive lung disease
A decrease in lung capacity as a result of fluid accumulation or loss of elasticity of the lung
-
Absorbents
Drugs that act by coating the wall of the gastrointestinal tract and absorbing the bacteria or toxins that cause diarhhea
-
Antidiarrheals
Drugs used to tx dirrhea and decreasing hypermotility (increased peristalsis)
-
Antiemetics
Antivomiting agents
-
Cannabinoids
Marijuana to alleviate n/v resulting from CA tx or AIDS
-
Cathartics
Drugs used to eliminate fecal matter
-
Chemoreceptor trigger zone (CTZ)
A cerebral center that lies near the medulla and causes vomiting when stimulated
-
Chloride channel activators
Drugs that activate chloride channels in the lining of the small intestine, leading to an increase in intestinal fluid secretion and motility
-
Emollients
Stool softeners and lubricants used to prevent constipation
-
Osmotics
Hyperosmolar laxatives, including salts or saline products, lactulose and glycerin
-
Purgatives
Harsh cathartics that cause a watery stool with abdominal cramping
-
Duodenal ulcer
Caused by a hypersecretion of acid from the stomach that passes to the duodenum because of (1) insufficient buffers to neutralize the gastric acid in the stomach (2) a defective or incomepetent pyloric sphincer (3) hypermotility of the stomach
-
Esophageal ulcer
Results from reflux of acidic secretion into the esophagus as a result of a defective or incompetent cardiac sphincter
-
Gastric mucosal barrier (GMB)
A thick, viscous, mucous material that provides a barrier between the mucosal lining and the acidic gastic secretions
-
Gastic ulcer
Frequently occurs because of a breakdown of the gastric mucosal barrier
-
GERD
Inflammation or erosion of the esophageal mucosa caused by a reflux of gastric acid content from the stomach into the esophagus
-
Histamine2 receptor antagonists
Popular drugs used in the tx of gastric and duodenal ulcers, they prevent acid reflux in the esophagus (reflux esophagitis)
-
Hydrochloric acid (HCl)
Acid released from the parietal cells of the stomach; influenced by histamine, gastin and acetylcholine
-
Pepsin
A digestive enzyme
-
Peptic ulcer
A broad term for an ulcer occuring in the esophagus, stomach or duodenum within the upper gi tract
-
Carbonic anhydrase nhibitors
Drugs that interfere with production of carbonic acid, which leads to decreased aqueous humor formation and decreased intraocular pressure
-
Cyclopedics
Agents that paralyze the muscles of accomodation
-
Miosis
Contraciton of the pupil
-
Miotic
Agents used to lower the IOP, thereby increasing blood flow to the retina and decreasing retinal damage and loss of vision
-
Mydriatics
Agents that dilate the pupil
-
Osmotics
Agents used preoperatively and postoperatively to decrease vitreous humor volume, thereby reducing the IOP
-
Keratolysis
Removal of the horny layer of the epidermis
|
|